Institutional investors hold a majority ownership of ABT through the 74.28% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended September 2017, these large investors purchased a net $8.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE OREGON INVESTMENT COUNCIL Bought 232.8 Thousand shares of Abbott Laboratories
SJUNDE AP-FONDEN Bought 199.5 Thousand shares of Abbott Laboratories
OSSIAM SA Bought 80.0 Thousand shares of Abbott Laboratories